Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Chue

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Journal of Psychopharmacology (Oxford, England)|October 19, 2006
The relationship between patient satisfaction and treatment outcomes in schizophreniaPierre Chue
Neuropsychiatric Disease and Treatment|March 21, 2009
Long-acting risperidone injection: efficacy, safety, and cost-effectiveness of the first long-acting atypical antipsychoticPierre Chue
Expert Review of Neurotherapeutics|October 9, 2009
Risperidone long-acting injectionPierre Chue
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 23, 2004
The assessment and management of antipsychotic-associated metabolic disturbances from a psychiatric perspectivePierre Chue
Acta Neuropsychiatrica|March 18, 2016
Compliance and convenience: do physicians and patients see depot medication differently?Pierre Chue
Current Pharmaceutical Design|December 1, 2012
Glycine reuptake inhibition as a new therapeutic approach in schizophrenia: focus on the glycine transporter 1 (GlyT1)Pierre Chue
Current Medical Research and Opinion|December 30, 2015
A review of aripiprazole long-acting injectionPierre Chue, James Chue
International Journal of Psychiatry in Clinical Practice|June 19, 2014
Minimising the risk of diabetes in patients with schizophrenia and bipolar disorderPierre Chue, Raphael Cheung
Journal of Psychiatry & Neuroscience : JPN|August 19, 2003
A review of olanzapine-associated toxicity and fatality in overdosePierre Chue, Peter Singer
Acta Neuropsychiatrica|March 18, 2016
The impact of weight gain associated with atypical antipsychotic use in schizophreniaPierre Chue, Raphael Cheung
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Journal of Psychopharmacology (Oxford, England)|October 19, 2006
The relationship between patient satisfaction and treatment outcomes in schizophreniaPierre Chue
Neuropsychiatric Disease and Treatment|March 21, 2009
Long-acting risperidone injection: efficacy, safety, and cost-effectiveness of the first long-acting atypical antipsychoticPierre Chue
Expert Review of Neurotherapeutics|October 9, 2009
Risperidone long-acting injectionPierre Chue
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 23, 2004
The assessment and management of antipsychotic-associated metabolic disturbances from a psychiatric perspectivePierre Chue
Acta Neuropsychiatrica|March 18, 2016
Compliance and convenience: do physicians and patients see depot medication differently?Pierre Chue
Current Pharmaceutical Design|December 1, 2012
Glycine reuptake inhibition as a new therapeutic approach in schizophrenia: focus on the glycine transporter 1 (GlyT1)Pierre Chue
Current Medical Research and Opinion|December 30, 2015
A review of aripiprazole long-acting injectionPierre Chue, James Chue
International Journal of Psychiatry in Clinical Practice|June 19, 2014
Minimising the risk of diabetes in patients with schizophrenia and bipolar disorderPierre Chue, Raphael Cheung
Journal of Psychiatry & Neuroscience : JPN|August 19, 2003
A review of olanzapine-associated toxicity and fatality in overdosePierre Chue, Peter Singer
Acta Neuropsychiatrica|March 18, 2016
The impact of weight gain associated with atypical antipsychotic use in schizophreniaPierre Chue, Raphael Cheung
Pageof 7